Pershing Square | Activist Presentation Deck

Slide schematic 7/7

callout 1/1 list 5/5 title 1/1

Components 7

primary bullet bullet bullet bullet bullet headline

Tools 1

list/bullet: In-licenses from one-product companies; Acquisitions of sub-scale companies without adequate distribution; Declining products neglected by other companies that can return to growth with promotion

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Slide 39 from an activist deck regarding Valeant Pharmaceuticals.